Research graph
References from COVID-19 has taught us that not all COPD exacerbations are created equal. Local targets link to admitted publications; unresolved targets remain external evidence.
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
10.1136/thorax.57.10.847 · 2002 · External reference
Susceptibility to exacerbation in chronic obstructive pulmonary disease
10.1056/nejmoa0909883 · 2010 · External reference
Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort
10.1378/chest.14-0655 · 2015 · External reference
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
10.1183/13993003.01339-2020 · 2021 · External reference
Impact and prevention of severe exacerbations of COPD: a review of the evidence
10.2147/copd.s139470 · 2017 · External reference
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
10.1056/nejmoa0805800 · 2008 · External reference
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
10.1016/s2213-2600(24)00409-0 · 2025 · External reference
Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review
10.1186/s12931-022-02123-5 · 2022 · External reference
10.1093/annalsats/aaoag084 · 2026 · Admitted local publication
Cardiovascular consequences of viral infections: from COVID to other viral diseases
10.1093/cvr/cvab315 · 2021 · External reference
